Nitroxyl Spin Label Contrast Enhancers for Magnetic Resonance Imaging
- 1 November 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 19 (6), 549-552
- https://doi.org/10.1097/00004424-198411000-00014
Abstract
Two nitroxyl spin label (NSL) compounds that are used experimentally as in vivo contrast enhancers in magnetic resonance (MR) imaging were tested for acute toxicity in rats and for genotoxic effects in cell cultures. These compounds, 2,2,5,5-tetramethyl-1-pyrrolidinyl-oxy-3-carboxylic acid (PCA) and 2,2,6,6-tetramethyl-1-oxido-4-piperidinyl-1-succinic acid (TES) and their hydroxylamine and amine derivatives did not induce sister chromatid exchanges or mutations in Chinese hamster ovary cells at the HGPRT or Na+/K+; ATPase loci. The acute LD50 doses in rats for PCA and TES are 15.1 mmol/kg or greater, suggesting relatively high tolerance.This publication has 3 references indexed in Scilit:
- Phytohaemagglutin-induced changes in spin label reduction in lymphocytes from tumor-bearing ratsBiochemical and Biophysical Research Communications, 1982
- NMR imaging produces no observable mutations or cytotoxicity in mammalian cellsAmerican Journal of Roentgenology, 1982
- Immunochemical Studies on the Poly-γ-D-glutamyl Capsule of Bacillus anthracis. II. The Synthesis of Eight Dipeptides and Four Tripeptides of Glutamic Acid*Biochemistry, 1966